Researchers develop 3D bioprinting technology for eliminating cancer cells

FHS
July 12, 2023
3:19 am

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

To pay off debt and stay open, Seres will sell microbiome pill to partner Nestlé

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 7, 2024

Nearly 60% of Healthcare Providers Experienced a Data Breach Since 2021

What You Should Know: Nearly 60% of healthcare providers experienced one or more security breaches and 45% experienced a data breach from an outside source

July 5, 2023

Study reveals daily food environment exposure shapes fast food habits

Study investigates the influence of daily exposure to various food environments on dietary choices, focusing on fast food outlet visits and revealing that proximity to

March 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.